ATE87485T1 - Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen. - Google Patents

Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen.

Info

Publication number
ATE87485T1
ATE87485T1 AT87100015T AT87100015T ATE87485T1 AT E87485 T1 ATE87485 T1 AT E87485T1 AT 87100015 T AT87100015 T AT 87100015T AT 87100015 T AT87100015 T AT 87100015T AT E87485 T1 ATE87485 T1 AT E87485T1
Authority
AT
Austria
Prior art keywords
cholecystokinin
respiratory
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT87100015T
Other languages
English (en)
Inventor
Alfio Bertolini
Original Assignee
Alfio Bertolini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfio Bertolini filed Critical Alfio Bertolini
Application granted granted Critical
Publication of ATE87485T1 publication Critical patent/ATE87485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87100015T 1986-01-10 1987-01-02 Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen. ATE87485T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19055/86A IT1204430B (it) 1986-01-10 1986-01-10 Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
EP87100015A EP0239716B1 (de) 1986-01-10 1987-01-02 Peptide der Cholecystokinin-Cerulein-Gruppe enthaltende pharmazeutische Zusammensetzungen zur Behandlung von respiratorischen und Herz-Kreislauf-Insuffizienzen

Publications (1)

Publication Number Publication Date
ATE87485T1 true ATE87485T1 (de) 1993-04-15

Family

ID=11154164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100015T ATE87485T1 (de) 1986-01-10 1987-01-02 Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen.

Country Status (8)

Country Link
US (1) US4794103A (de)
EP (1) EP0239716B1 (de)
JP (1) JP2534998B2 (de)
AT (1) ATE87485T1 (de)
DE (1) DE3785066T2 (de)
ES (1) ES2053454T3 (de)
IT (1) IT1204430B (de)
ZA (1) ZA87149B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
EP0522596A1 (de) * 1989-04-03 1993-01-13 Kabi Pharmacia AB Methode und Mittel zur Herbeiführung der Verengung der Augenpupille
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
JPH08500577A (ja) * 1992-07-15 1996-01-23 ユニヴァーシティ オブ サウス フロリダ パニック障害の治療に関連するｃｃｋペプチドの血中濃度
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
CA2328501A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Prevention and treatment of hypergastrinemia
DE69916273T2 (de) * 1998-06-18 2005-05-19 Vecta Ltd. Verwendung von gastrin fragmenten oder sythetischen analogen von gastrin zur herstellung eines arzneimittels zur behandlung der helicobacter pylori assozierten störungen
SE9901578D0 (sv) * 1999-05-03 1999-05-03 Karolinska Innovations Ab New use of substance in PNS
JP2005508838A (ja) 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
EP1794586B1 (de) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoklonale antikörper gegen progastrin
US20080077949A1 (en) * 2006-09-22 2008-03-27 Inventec Corporation Rotating data storage device anti-shake mechanism
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
KR102772810B1 (ko) 2017-06-15 2025-02-28 캔서 어드밴시스 아이엔씨 종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법
RU2667466C1 (ru) * 2017-11-27 2018-09-19 Общество с ограниченной ответственностью "МЕДИНВЕСТ" Пептидное соединение, восстанавливающее функцию органов дыхания и обладающее иммуномодулирующим действием

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723406A (en) * 1969-12-23 1973-03-27 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor
DE2256445C3 (de) * 1972-11-17 1981-11-05 Hoechst Ag, 6000 Frankfurt Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE3138233A1 (de) * 1981-09-25 1983-04-07 Farmitalia Carlo Erba S.p.A., 20159 Milano Neuropsychotropisches arzneimittel

Also Published As

Publication number Publication date
IT1204430B (it) 1989-03-01
EP0239716A2 (de) 1987-10-07
JP2534998B2 (ja) 1996-09-18
EP0239716B1 (de) 1993-03-31
ZA87149B (en) 1987-09-30
EP0239716A3 (en) 1990-05-23
DE3785066D1 (de) 1993-05-06
JPS62246521A (ja) 1987-10-27
US4794103A (en) 1988-12-27
DE3785066T2 (de) 1993-07-08
ES2053454T3 (es) 1994-08-01
IT8619055A0 (it) 1986-01-10

Similar Documents

Publication Publication Date Title
DE3785066D1 (de) Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herz-kreislauf-insuffizienzen.
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
BG86132A (bg) Производни на пиридазинамин
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
DE69939705D1 (de) Behandlung der pompeschen krankheit
NO944752D0 (no) Rensede DNase-former
DE69033521D1 (de) Verwendung von arginin als immunstimulator
DE69929188D1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
ATE411039T1 (de) Verwendung von thrombopoietin als medikament zur therapie und vorbeugung der thrombocytopenie
EP0264750A3 (de) Wachstumshormon-Releasingfaktor-Analoga
NO882239D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
ATE79272T1 (de) Acth(1-24) enthaltende pharmazeutische zusammensetzungen zur therapie von schockzustaenden und von respiratorischen und herzkreislauf-insuffizienzen.
KR0126677B1 (ko) 항바이러스성 약제학적 조성물
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
JPS6426598A (en) Calcitonin gene related peptide derivative
Wleklik et al. Tuftsin, a natural peptide with antiviral activity-structural basis of its action
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
DE4303530C2 (de) Pharmazeutische Verwendung eines Enkephalins
ES2036006T3 (es) Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios.